( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



Dhiman Kapil*, Sharma Jyoti*, Bhardwaj Shubham and Kumar Damit


Radiopharmaceutical basically deals with the application of radioactive nuclides as a therapeutic agent in different diseases treatment and somewhere also as sterilising agent. The therapeutic action depends on the radiation potential of nuclides which is utilised to terminate the cancerous cell by either implanting nuclides close to the tumour or by selective delivery of nuclides to the malignant cells using immunobiology. Radionuclides are outlined to be more lethal towards malignant cells in comparison to normal cells, and this stimulated the researchers to use radionuclides in cancer treatment. ―TELETHERAPY‖ one of the method for treating deep settled tumours is through the application of a direct powerful narrow beam of gamma rays [ϒ], emitted by an artificial isotope, into the tumour. Cobalt-60 is most commonly used isotope for teletherapy. In “BRACHYTHERAPY” compact source of radiation is implanted for treatment of superficial tumours. The recent advancement in drug delivery stimulated the focus toward the application of monoclonal antibodies (mAb‘s) for selective targeting of the malignant cells. Previously the mAb‘s used were derived from mouse which is recently seen to form HAMA (Human Anti-Mouse Antibody). Genetically engineered and humanised mAb‘s appear to be one of the most promising strategies to avoid HAMA formation. This review include the detailed study and the recent application of radioisotopes like 90Y, 212Bi, 213Bi,123 I & 124 I in treatment of cancer through radio immunotherapy.

Keywords: Radiopharmaceuticals, Radionuclides, HAMA (Human Anti-Mouse Antibody), Radio immunotherapy, mAb‘s.

[Full Text Article]



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 June 2021 Issue has been Published, Kindly check it on


    JUNE Issue has been successfully launched on 1 June 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )